Assure Holdings CORP

Assure Holdings Corp. has reached a settlement with Wellgistics Health, Inc. (formerly Danam Health, Inc.), resolving disputes related to a terminated merger agreement and cancelling a $1 million convertible note.

Assure Holdings Corp. has appointed John Price as Chief Financial Officer, effective October 1, 2024, following the resignation of Paul Webster.

Assure Holdings Corp. issued 2,477,082 shares of common stock in exchange for $2.129 million in principal amount of convertible debentures and $348,093 in accrued interest.

Assure Holdings Corp. has amended its debt settlement agreement with Centurion Financial Trust, involving asset assignments, share issuance, and a potential cash payment to resolve a $11 million debenture.

Assure Holdings Corp. has announced the cancellation of its special meeting of stockholders previously scheduled for August 21, 2024.

Assure Holdings Corp. has agreed to sell all of its subsidiaries in exchange for the buyer assuming approximately $2.6 million in debt and other considerations.

Assure Holdings Corp. reports a net loss of $4.016 million for the six months ended June 30, 2024, amid strategic shifts including the sale of clinical assets and termination of a merger agreement.

Assure Holdings Corp. announces its Q1 2024 financial results, highlighting a strategic shift involving the sale of clinical operations and a pending merger with Danam Health, Inc.

Assure Holdings Corp. divests its clinical operations and plans a merger with Danam Health, marking a significant strategic shift.

Assure Holdings Corp. files an amended S-1 registration statement for a proposed public offering of common stock and warrants as it faces potential delisting from the Nasdaq.

Assure Holdings Corp. files an S-1 registration statement for a proposed unit offering, aiming to raise capital for operations, strategic exploration, and debt repayment.